• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名葡萄牙肝片吸虫病患者在接受多疗程三氯苯达唑治疗后出现治疗失败。

Treatment failure after multiple courses of triclabendazole in a Portuguese patient with fascioliasis.

作者信息

Branco Elsa Alves, Ruas Rogerio, Nuak João, Sarmento António

机构信息

Infectious Diseases Department, Centro Hospitalar de São João EPE, Porto, Portugal.

Infectious Diseases Department, Centro Hospitalar de São João EPE, Porto, Portugal

出版信息

BMJ Case Rep. 2020 Mar 18;13(3):e232299. doi: 10.1136/bcr-2019-232299.

DOI:10.1136/bcr-2019-232299
PMID:32193176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7101001/
Abstract

Fascioliasis is a trematode flatworm infection caused by Humans are incidental hosts, and the infection is most often acquired by eating watercress grown in contaminated water in livestock-rearing areas. Triclabendazole is the only highly effective treatment, with a reported cure rate of >90%. Treatment failure may be due to several factors, though resistance is rare in humans and scarcely reported, most probably a reflection of the widespread use of anthelmintics in livestock. There are three papers describing cases of treatment failure, possibly due to resistance, in the Netherlands, Chile and Peru. We document for the first time one case of failure after multiple treatment courses with triclabendazole in Portugal, probably due to resistance to the anthelmintic. Our aim is to alert for the emergence of resistance across continents, with consequent predictable difficulties in the management of the disease and encourage more investigation in the field.

摘要

肝片吸虫病是由肝片吸虫引起的一种吸虫扁虫感染。人类是偶然宿主,感染通常是由于食用了在畜牧区受污染水中生长的水田芥所致。三氯苯达唑是唯一一种高效治疗药物,据报道治愈率>90%。治疗失败可能由多种因素导致,尽管人类耐药情况罕见且鲜有报道,这很可能反映了驱虫药在牲畜中的广泛使用。有三篇论文描述了在荷兰、智利和秘鲁出现的可能因耐药导致治疗失败的病例。我们首次记录了葡萄牙一例在多次使用三氯苯达唑治疗疗程后出现治疗失败的病例,可能是由于对该驱虫药产生了耐药性。我们的目的是警惕各大洲出现耐药情况,以及随之而来的可预见的疾病管理困难,并鼓励在该领域开展更多调查。

相似文献

1
Treatment failure after multiple courses of triclabendazole in a Portuguese patient with fascioliasis.一名葡萄牙肝片吸虫病患者在接受多疗程三氯苯达唑治疗后出现治疗失败。
BMJ Case Rep. 2020 Mar 18;13(3):e232299. doi: 10.1136/bcr-2019-232299.
2
Triclabendazole in the treatment of human fascioliasis: a review.三氯苯达唑治疗人体片形吸虫病:综述。
Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):797-804. doi: 10.1093/trstmh/trz093.
3
Induced Hepatic Abscess Treated with Triclabendazole.三氯苯达唑治疗诱导性肝脓肿。
Korean J Gastroenterol. 2021 Jan 25;77(1):39-44. doi: 10.4166/kjg.2020.152.
4
Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales.三英格兰和威尔士个地区的绵羊养殖场存在三氯苯达唑对肝片吸虫无效的情况。
Vet Rec. 2019 Apr 20;184(16):502. doi: 10.1136/vr.105209. Epub 2019 Mar 1.
5
Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.秘鲁库斯科地区片形吸虫病患者多疗程使用三氯苯达唑后的治疗失败:病例系列
PLoS Negl Trop Dis. 2016 Jan 25;10(1):e0004361. doi: 10.1371/journal.pntd.0004361. eCollection 2016 Jan.
6
Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru.秘鲁库斯科地区学龄前和学龄儿童肝片吸虫感染的三氯苯达唑治疗失败情况
Emerg Infect Dis. 2021 Jul;27(7):1850-1857. doi: 10.3201/eid2707.203900.
7
Flukicide efficacy against Fasciola hepatica of Triclabendazole and Nitroxynil in cattle of the central valley of Chile.三氯苯达唑和硝碘酚腈对智利中央山谷地区牛体内肝片吸虫的杀吸虫效果
Rev Bras Parasitol Vet. 2019 Jan-Mar;28(1):164-167. doi: 10.1590/S1984-296120180089. Epub 2019 Mar 11.
8
Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures.三氯苯达唑治疗人体片形吸虫病及治疗失败的威胁。
Expert Rev Anti Infect Ther. 2021 Jul;19(7):817-823. doi: 10.1080/14787210.2021.1858798. Epub 2020 Dec 14.
9
Human Fascioliasis (Liver Fluke Disease) in Hawai'i: Case Report and Review of Human Fascioliasis Acquired in the United States.夏威夷人体片形吸虫病(肝片吸虫病):病例报告及美国获得性人体片形吸虫病综述。
Hawaii J Health Soc Welf. 2021 Sep;80(9):212-217.
10
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.蒿甲醚和OZ78对三氯苯达唑耐药性肝片吸虫的活性。
Trans R Soc Trop Med Hyg. 2007 Dec;101(12):1219-22. doi: 10.1016/j.trstmh.2007.07.012. Epub 2007 Oct 1.

引用本文的文献

1
An overview of fasciolosis in human and cattle populations in New Valley, Egypt.埃及新河谷地区人类和牛群中的片形吸虫病概述。
Front Vet Sci. 2025 Aug 20;12:1572946. doi: 10.3389/fvets.2025.1572946. eCollection 2025.
2
Hepatobiliary fascioliasis: A neglected re-emerging threat, its diagnostic and management challenges.肝胆片形吸虫病:一种被忽视的再度出现的威胁,及其诊断和管理挑战。
World J Gastrointest Pathophysiol. 2025 Jun 22;16(2):107599. doi: 10.4291/wjgp.v16.i2.107599.
3
Human Fascioliasis in Portugal: A Case Report.葡萄牙的人体片形吸虫病:一例报告。
Cureus. 2024 Nov 26;16(11):e74527. doi: 10.7759/cureus.74527. eCollection 2024 Nov.
4
New benzimidazole derivative compounds with in vitro fasciolicidal properties.具有体外杀双腔吸虫特性的新型苯并咪唑衍生物化合物。
Parasit Vectors. 2024 Apr 3;17(1):173. doi: 10.1186/s13071-024-06224-6.
5
Transcriptomic analysis supports a role for the nervous system in regulating growth and development of Fasciola hepatica juveniles.转录组分析支持神经系统在调控肝片形吸虫幼虫生长和发育中的作用。
PLoS Negl Trop Dis. 2022 Nov 7;16(11):e0010854. doi: 10.1371/journal.pntd.0010854. eCollection 2022 Nov.
6
Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru.秘鲁库斯科地区学龄前和学龄儿童肝片吸虫感染的三氯苯达唑治疗失败情况
Emerg Infect Dis. 2021 Jul;27(7):1850-1857. doi: 10.3201/eid2707.203900.
7
Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.人体肝片吸虫病:当前的流行病学现状以及诊断、治疗和控制策略
Res Rep Trop Med. 2020 Nov 26;11:149-158. doi: 10.2147/RRTM.S237461. eCollection 2020.
8
Towards the comprehension of fasciolosis (re-)emergence: an integrative overview.迈向 Fasciolosis(再)流行的理解:综合概述。
Parasitology. 2021 Apr;148(4):385-407. doi: 10.1017/S0031182020002255. Epub 2020 Dec 2.

本文引用的文献

1
Current Threat of Triclabendazole Resistance in Fasciola hepatica.肝片吸虫对三氯苯达唑耐药性的当前威胁
Trends Parasitol. 2016 Jun;32(6):458-469. doi: 10.1016/j.pt.2016.03.002. Epub 2016 Apr 2.
2
Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.秘鲁库斯科地区片形吸虫病患者多疗程使用三氯苯达唑后的治疗失败:病例系列
PLoS Negl Trop Dis. 2016 Jan 25;10(1):e0004361. doi: 10.1371/journal.pntd.0004361. eCollection 2016 Jan.
3
[Resistant human fasciolasis: report of four patients].[抗药型人体肝片吸虫病:4例患者报告]
Rev Med Chil. 2014 Oct;142(10):1330-3. doi: 10.4067/S0034-98872014001000014.
4
Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.P-糖蛋白抑制剂R(+)-维拉帕米对三氯苯达唑耐药肝片吸虫分离株药物敏感性的影响
Vet Parasitol. 2013 Jul 1;195(1-2):72-86. doi: 10.1016/j.vetpar.2013.03.007. Epub 2013 Mar 22.
5
Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.荷兰出现对三氯苯达唑耐药的人体肝片吸虫感染病例。
Emerg Infect Dis. 2012 Jun;18(6):1028-9. doi: 10.3201/eid1806.120302.
6
Clinical presentation and management of Fasciola hepatica infection: single-center experience.肝片形吸虫感染的临床表现和治疗:单中心经验。
World J Gastroenterol. 2011 Nov 28;17(44):4899-904. doi: 10.3748/wjg.v17.i44.4899.
7
Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trials.青蒿琥酯治疗埃及慢性片形吸虫病的疗效和安全性:探索性 2 期试验。
PLoS Negl Trop Dis. 2011 Sep;5(9):e1285. doi: 10.1371/journal.pntd.0001285. Epub 2011 Sep 6.
8
Endoscopic ultrasound in biliary fasciolosis.内镜超声在胆道片形吸虫病中的应用
Indian J Gastroenterol. 2010 Jun;29(3):128. doi: 10.1007/s12664-010-0029-9.
9
Endoscopic management of biliary parasitic diseases.胆道寄生虫病的内镜治疗。
Dig Dis Sci. 2010 May;55(5):1472-8. doi: 10.1007/s10620-009-0850-0. Epub 2009 Jun 10.
10
Triclabendazole progress report, 2005-2009: an advancement of learning?三氯苯达唑进展报告,2005 - 2009年:知识的进步?
J Helminthol. 2009 Jun;83(2):139-50. doi: 10.1017/S0022149X09321173. Epub 2009 Apr 15.